Novel 2-mercapto imidazole and triazole derivatives as potent TGR5 receptor agonists
TGR5 is a bile acid G protein-coupled receptor (GPCR), which is an attractive therapeutic target for the treatment of obesity, and its highly associated Type 2 diabetes. Activation of TGR5 promotes secretion of glucagon like peptide-1 (GLP-1) and activates insulin secretion. Series of novel 2-mercap...
Main Authors: | Sameer Agarwal, Santosh Sasane, Jeevan Kumar, Brijesh Darji, Hitesh Bhayani, Shubhangi Soman, Neelima Kulkarni, Mukul Jain |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-03-01
|
Series: | Medicine in Drug Discovery |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590098619300028 |
Similar Items
-
Identification and validation of a potent synthetic TGR5 agonist that improves metabolism, inflammation and atherosclerosis
by: Moullan, Norman
Published: (2015) -
Effect of mercapto and methyl groups on the efficiency of imidazole and benzimidazole-based inhibitors of iron corrosion
by: Ingrid Milošev, et al.
Published: (2016-05-01) -
The chemistry of mercapto- and thione- substituted 1,2,4-triazoles and their utility in heterocyclic synthesis
by: Raafat M. Shaker
Published: (2006-06-01) -
Discovery, optimization, and evaluation of non-bile acid FXR/TGR5 dual agonists
by: Sachiho Miyata, et al.
Published: (2021-04-01) -
Identification of degradation impurity of TGR5 receptor agonist-ZY12201 by LC–MS technique during force degradation study
by: Chandrakant Sojitra, et al.
Published: (2021-05-01)